Allogene Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Allogene Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Allogene Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Allogene Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $19M | 8.2M | 2.33 |
| 2024-03-31 | $37M | 8.2M | 4.47 |
| 2023-12-31 | $29M | 9.0M | 3.21 |
| 2023-09-30 | $34M | 11M | 3.17 |
| 2023-06-30 | $37M | 7.5M | 4.97 |
| 2023-03-31 | $36M | 7.3M | 4.94 |
| 2022-12-31 | $46M | 7.3M | 6.29 |
| 2022-06-30 | $96M | 8.4M | 11.40 |
| 2022-03-31 | $62M | 6.8M | 9.11 |
| 2021-09-30 | $172M | 6.7M | 25.70 |
| 2021-06-30 | $172M | 6.6M | 26.08 |
| 2021-03-31 | $210M | 6.0M | 35.30 |
| 2020-12-31 | $146M | 5.8M | 25.24 |
| 2020-09-30 | $213M | 5.7M | 37.71 |
| 2020-06-30 | $252M | 5.9M | 42.82 |
| 2020-03-31 | $80M | 4.1M | 19.44 |
| 2019-12-31 | $103M | 3.9M | 25.98 |
| 2019-09-30 | $108M | 3.9M | 27.45 |
| 2019-03-31 | $61M | 2.1M | 28.91 |
| 2018-12-31 | $55M | 2.0M | 26.92 |